Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 264
7
Diseases
14
Unique genes
0.240
Avg. similarity score
Specific learning disability
Most-connected disease (5 links)
Disease
Searched: Developmental delay with behavioral abnormalities
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Developmental delay with behavioral abnormalities
Specific learning disability
Microcephalic dwarfism
Tatton-Brown-Rahman overgrowth syndrome
heyn-sproul-jackson syndrome
Clonal cytopenia of undetermined significance
coffin-lowry syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Specific learning disability | 5 | 5 | 12 |
| Microcephalic dwarfism | 4 | 4 | 1 |
| Tatton-Brown-Rahman overgrowth syndrome | 4 | 4 | 1 |
| heyn-sproul-jackson syndrome | 4 | 4 | 1 |
| Clonal cytopenia of undetermined significance | 3 | 3 | 3 |
| Developmental delay with behavioral abnormalities | 1 | 1 | 1 |
| coffin-lowry syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| DNMT3A | 5 / 7 | Clonal cytopenia of undetermined significance, heyn-sproul-jackson syndrome, Microcephalic dwarfism, Specific learning disability and 1 more |
| ADGRL1 | 2 / 7 | Developmental delay with behavioral abnormalities, Specific learning disability |
| RPS6KA3 | 2 / 7 | coffin-lowry syndrome, Specific learning disability |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Toxoplasmosis | KEGG | 4 / 112 | 71.5× | 1.06e-7 | 6.89e-6 ✓ sig. |
| Tuberculosis | KEGG | 4 / 181 | 44.2× | 7.31e-7 | 3.71e-5 ✓ sig. |
| Interleukin-10 signaling | Reactome | 3 / 47 | 128× | 1.11e-6 | 5.37e-5 ✓ sig. |
| Cytokine-cytokine receptor interaction | KEGG | 4 / 298 | 26.9× | 5.36e-6 | 2.01e-4 ✓ sig. |
| Viral protein interaction with cytokine and cytokine receptor | KEGG | 3 / 100 | 60.1× | 1.10e-5 | 3.63e-4 ✓ sig. |
| JAK-STAT signaling pathway | KEGG | 3 / 168 | 35.7× | 5.21e-5 | 1.32e-3 ✓ sig. |
| Human cytomegalovirus infection | KEGG | 3 / 226 | 26.6× | 1.26e-4 | 2.70e-3 ✓ sig. |
| Intestinal immune network for IgA production | KEGG | 2 / 50 | 80.1× | 2.52e-4 | 4.68e-3 ✓ sig. |
| Malaria | KEGG | 2 / 50 | 80.1× | 2.52e-4 | 4.68e-3 ✓ sig. |
| Inflammatory bowel disease | KEGG | 2 / 66 | 60.7× | 4.40e-4 | 7.21e-3 ✓ sig. |
| Leishmaniasis | KEGG | 2 / 78 | 51.3× | 6.14e-4 | 9.37e-3 ✓ sig. |
| Influenza Virus Induced Apoptosis | Reactome | 1 / 2 | 1,001× | 9.99e-4 | 1.35e-2 ✓ sig. |
| The IPAF inflammasome | Reactome | 1 / 2 | 1,001× | 9.99e-4 | 1.35e-2 ✓ sig. |
| TGFBR2 MSI Frameshift Mutants in Cancer | Reactome | 1 / 2 | 1,001× | 9.99e-4 | 1.35e-2 ✓ sig. |
| Chagas disease | KEGG | 2 / 103 | 38.9× | 1.07e-3 | 1.43e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| ERBB signaling pathway | GO:0038127 | 2 / 4 | 667× | 3.12e-6 | 2.10e-4 ✓ sig. |
| Bergmann glial cell differentiation | GO:0060020 | 2 / 11 | 243× | 2.86e-5 | 1.19e-3 ✓ sig. |
| positive regulation of cell differentiation | GO:0045597 | 3 / 83 | 48.2× | 2.97e-5 | 1.23e-3 ✓ sig. |
| hormone metabolic process | GO:0042445 | 2 / 25 | 107× | 1.55e-4 | 4.28e-3 ✓ sig. |
| insulin-like growth factor receptor signaling pathway | GO:0048009 | 2 / 33 | 80.9× | 2.72e-4 | 6.37e-3 ✓ sig. |
| hormone-mediated signaling pathway | GO:0009755 | 2 / 42 | 63.6× | 4.41e-4 | 8.96e-3 ✓ sig. |
| regulation of response to nutrient levels | GO:0032107 | 1 / 1 | 1,335× | 7.49e-4 | 1.28e-2 ✓ sig. |
| negative regulation of cortisol secretion | GO:0051463 | 1 / 1 | 1,335× | 7.49e-4 | 1.28e-2 ✓ sig. |
| negative regulation of growth hormone secretion | GO:0060125 | 1 / 1 | 1,335× | 7.49e-4 | 1.28e-2 ✓ sig. |
| intestinal epithelial cell migration | GO:0061582 | 1 / 1 | 1,335× | 7.49e-4 | 1.28e-2 ✓ sig. |
| cellular response to amino acid starvation | GO:0034198 | 2 / 60 | 44.5× | 9.00e-4 | 1.45e-2 ✓ sig. |
| epidermal growth factor receptor signaling pathway | GO:0007173 | 2 / 64 | 41.7× | 1.02e-3 | 1.56e-2 ✓ sig. |
| TORC1 signaling | GO:0038202 | 2 / 67 | 39.8× | 1.12e-3 | 1.66e-2 ✓ sig. |
| cytosine metabolic process | GO:0019858 | 1 / 2 | 667× | 1.50e-3 | 1.95e-2 ✓ sig. |
| microvillus organization | GO:0032528 | 1 / 2 | 667× | 1.50e-3 | 1.95e-2 ✓ sig. |